TCT 213: Validation Study of Digital Twin Based Pre- and Post-TAVR Hemodynamics Analysis
Presenter:
We Recommend
Disclosures
Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:
- Consultant Fee/Honoraria/Speaker's Bureau - Medtronic; Boston Scientific Corporation; Shockwave Medical; Teleflex; Cardiac Dimensions; AstraZenca; Recor Medical; Daiichi-Sankyo/Elil Lilly and Company
- Grant Support/Research Contract - Abbott; Edwards Lifesciences; Boehringer Ingelheim